* NuVasive Inc NUVA.OQ NUVA.O is expected to show a rise
in
quarterly revenue when it reports results on February 23.
* The San Diego California-based company is expected to
report a
2.4% increase in revenue to $298.951 million from $291.81
million a year ago, according to the mean estimate from 15
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for NuVasive Inc is for
earnings of 49 cents per share. For the same quarter last year,
the company reported earnings of 59 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 7
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for NuVasive
Inc is
$60, about 15.4% above its last closing price of $50.79.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 0.52 0.53 0.32 Missed -40.1
Jun. 30 2021 0.46 0.44 0.60 Beat 35
Mar. 31 2021 0.36 0.35 0.37 Beat 5.9
Dec. 31 2020 0.55 0.55 0.59 Beat 6.4
Sep. 0.23 0.24 0.55 Beat 130.9
30 2020
Jun. 30 2020 -0.40 -0.47 -0.40 Beat 15.6
Mar. 31 2020 0.38 0.41 0.48 Beat 17.3
Dec. 31 2019 0.64 0.64 0.73 Beat 14.3
This summary was machine generated February 22 at 03:05 GMT.
All figures in US dollars unless otherwise stated